retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial is gaining attention in metabolic research for its activity on GIP, GLP-1, and Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Pay in 4 interest-free payments of $6.90 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13

























